Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 23:bjophthalmol-2018-313156.
doi: 10.1136/bjophthalmol-2018-313156. Online ahead of print.

Evaluation of a deep learning image assessment system for detecting severe retinopathy of prematurity

Collaborators, Affiliations

Evaluation of a deep learning image assessment system for detecting severe retinopathy of prematurity

Travis K Redd et al. Br J Ophthalmol. .

Abstract

Background: Prior work has demonstrated the near-perfect accuracy of a deep learning retinal image analysis system for diagnosing plus disease in retinopathy of prematurity (ROP). Here we assess the screening potential of this scoring system by determining its ability to detect all components of ROP diagnosis.

Methods: Clinical examination and fundus photography were performed at seven participating centres. A deep learning system was trained to detect plus disease, generating a quantitative assessment of retinal vascular abnormality (the i-ROP plus score) on a 1-9 scale. Overall ROP disease category was established using a consensus reference standard diagnosis combining clinical and image-based diagnosis. Experts then ranked ordered a second data set of 100 posterior images according to overall ROP severity.

Results: 4861 examinations from 870 infants were analysed. 155 examinations (3%) had a reference standard diagnosis of type 1 ROP. The i-ROP deep learning (DL) vascular severity score had an area under the receiver operating curve of 0.960 for detecting type 1 ROP. Establishing a threshold i-ROP DL score of 3 conferred 94% sensitivity, 79% specificity, 13% positive predictive value and 99.7% negative predictive value for type 1 ROP. There was strong correlation between expert rank ordering of overall ROP severity and the i-ROP DL vascular severity score (Spearman correlation coefficient=0.93; p<0.0001).

Conclusion: The i-ROP DL system accurately identifies diagnostic categories and overall disease severity in an automated fashion, after being trained only on posterior pole vascular morphology. These data provide proof of concept that a deep learning screening platform could improve objectivity of ROP diagnosis and accessibility of screening.

Keywords: child health (paediatrics); public health; retina; telemedicine.

PubMed Disclaimer

Conflict of interest statement

Competing interests: MFC is an unpaid member of the Scientific Advisory Board for Clarity Medical Systems (Pleasanton, California, USA), a Consultant for Novartis (Basel, Switzerland) and an initial member of Inteleretina, LLC (Honolulu, Hawaii, USA). RVPC is a Scientific Advisory Board member for Visunex Medical Systems (Fremont, California, USA) and a Consultant for Alcon (Fort Worth, Texas, USA), Allergan (Irvine, California, USA) and Bausch and Lomb (St. Louis, Missouri, USA). JPC is a consultant to Allergan (Irvine, California, USA).

Figures

Figure 1
Figure 1
Distributions of Imaging & Informatics retinopathy of prematurity deep learning (i-ROP DL) vascular severity score in eye examinations with different reference standard diagnoses. Data are shown for 4861 eye examinations. In this data set, a hypothetical referral cut-off score of ‘3’ would effectively exclude 89% of examinations with no or mild ROP, while capturing 94% of examinations with type 1 ROP.
Figure 2
Figure 2
Association between Imaging & Informatics retinopathy of prematurity deep learning (i-ROP DL) vascular severity score and ordered ranking of overall ROP disease severity of 100 images by five experts. In this data set, a hypothetical referral cut-off score of ‘3’ would effectively exclude 94% of cases of no or mild ROP, while capturing 100% of cases of type 1 ROP.

References

    1. Chiang MF, Jiang L, Gelman R, et al. Interexpert agreement of plus disease diagnosis in retinopathy of prematurity. Arch Ophthalmol 2007;125:875–80. - PubMed
    1. Braverman RS, Enzenauer RW. Socioeconomics of retinopathy of prematurity in-hospital care. Arch Ophthalmol 2010;128:1055–8. - PubMed
    1. Sommer A, Taylor HR, Ravilla TD, et al. Challenges of ophthalmic care in the developing world. JAMA Ophthalmol 2014;132:640–4. - PMC - PubMed
    1. Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003;121:1684–96. - PubMed
    1. Fleck BW, Williams C, Juszczak E, et al. An international comparison of retinopathy of prematurity grading performance within the Benefits of Oxygen Saturation Targeting II trials. Eye 2018;32:74–80. - PMC - PubMed